Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$332M |
| 2 |
ExxonMobil
XOM
|
+$283M |
| 3 |
Verizon
VZ
|
+$165M |
| 4 |
Yum China
YUMC
|
+$137M |
| 5 |
Chevron
CVX
|
+$129M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$941M |
| 2 |
Dimensional International Core Equity 2 ETF
DFIC
|
+$862M |
| 3 |
Dimensional International High Profitability ETF
DIHP
|
+$427M |
| 4 |
Dimensional International Small Cap Value ETF
DISV
|
+$421M |
| 5 |
Apple
AAPL
|
+$219M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.74% |
| 2 | Technology | 15.25% |
| 3 | Industrials | 12.58% |
| 4 | Healthcare | 11.81% |
| 5 | Consumer Discretionary | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RPTX
3276
DELISTED
Repare Therapeutics
RPTX
| $157K | ﹤0.01% |
12,979
-28,867
| -69% | -$372K |
|
3277
Alaunos Therapeutics
TCRT
$4.64M
| $157K | ﹤0.01% |
609
-93
| -13% | -$27K |
|
3278
Mustang Bio
MBIO
$4.5M
| $155K | ﹤0.01% |
441
-118
| -21% | -$54.7K |
|
3279
Cosan
CSAN
$3.09B
| $153K | ﹤0.01% |
+11,877
| New | +$171K |
|
|
VMEO
3280
DELISTED
Vimeo
VMEO
| $151K | ﹤0.01% |
37,704
-10,030
| -21% | -$59.3K |
|
|
BCEL
3281
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $151K | ﹤0.01% |
96,209
+36,282
| +61% | +$74.6K |
|
|
BNR
3282
Burning Rock Biotech
BNR
$99.1M
| $149K | ﹤0.01% |
6,216
+3,450
| +125% | +$111K |
|
3283
Cytosorbents Corp
CTSO
$23.4M
| $149K | ﹤0.01% |
109,640
-75,989
| -41% | -$148K |
|
3284
Jerash Holdings
JRSH
$56.8M
| $149K | ﹤0.01% |
35,105
+6,582
| +23% | +$33.9K |
|
|
TAIT
3285
DELISTED
Taitron Components
TAIT
| $148K | ﹤0.01% |
38,232
+4,668
| +14% | +$17.8K |
|
3286
Energy Services of America
ESOA
$283M
| $146K | ﹤0.01% |
50,923
+13,711
| +37% | +$36.1K |
|
3287
ACM Research
ACMR
$4.86B
| $145K | ﹤0.01% |
11,667
-209,895
| -95% | -$3.41M |
|
3288
Cullinan Oncology
CGEM
$1.06B
| $145K | ﹤0.01% |
+11,284
| New | +$152K |
|
3289
Dolphin Entertainment
DLPN
$14.7M
| $145K | ﹤0.01% |
27,272
-4,151
| -13% | -$34.4K |
|
|
DBTX
3290
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $143K | ﹤0.01% |
+41,341
| New | +$188K |
|
3291
Barnwell Industries
BRN
$14.7M
| $142K | ﹤0.01% |
53,704
| – | – |
|
3292
ADMA Biologics
ADMA
$1.99B
| $141K | ﹤0.01% |
58,179
-5,783
| -9% | -$13.9K |
|
|
LYLT
3293
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
| $138K | ﹤0.01% |
113,043
-180,045
| -61% | -$468K |
|
3294
Usio Inc
USIO
$51.6M
| $137K | ﹤0.01% |
106,076
-33,708
| -24% | -$61.8K |
|
|
DRRX
3295
DELISTED
DURECT Corp
DRRX
| $136K | ﹤0.01% |
23,582
-2,742
| -10% | -$16.7K |
|
3296
Envela
ELA
$540M
| $136K | ﹤0.01% |
26,931
+12,200
| +83% | +$86.4K |
|
3297
Puma Biotechnology
PBYI
$398M
| $136K | ﹤0.01% |
+57,305
| New | +$167K |
|
3298
Shattuck Labs
STTK
$633M
| $136K | ﹤0.01% |
+50,434
| New | +$189K |
|
|
NVNO
3299
enVVeno Medical
NVNO
$7.12M
| $135K | ﹤0.01% |
+614
| New | +$131K |
|
3300
Paysign
PAYS
$496M
| $135K | ﹤0.01% |
57,273
+14,934
| +35% | +$35.8K |
|
Similar funds
Dimensional Fund Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Dimensional Fund Advisors held 3,606 positions worth $260B, down 6.6% from $279B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q3 2022 filing shows 143 new, 1,920 increased, 1,329 reduced and 119 closed positions. Its largest new stake was Yum China: 2,857,283 shares worth $135M. The largest sale was Dimensional Emerging Markets Core Equity 2 ETF, an estimated $941M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
- Dimensional Fund Advisors's largest Q3 2022 buy was Yum China: 2,857,283 shares worth $135M.
- Dimensional Fund Advisors added most to Meta Platforms (Facebook) in Q3 2022, an estimated $332M increase.
- Dimensional Fund Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $219M.
- Dimensional Fund Advisors fully exited Dimensional Emerging Markets Core Equity 2 ETF in Q3 2022, selling an estimated $941M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $260B portfolio in Q3 2022.
- Dimensional Fund Advisors opened 143 new positions and closed 119 in Q3 2022.
- Dimensional Fund Advisors's portfolio value fell 6.6% quarter-over-quarter to $260B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.